Inhibitors such as camostat and nafamostat have shown guarantee in hindering TMPRSS2 activity, possibly preventing virus entry and reproduction, offering an intriguing treatment option for addressing influenza and coronavirus infections to prevent viral entry while concurrently modulating the inflammatory response to reduce disease extent [48]. The gene discussed is TMPRSS2; the disease is influenza.